Literature DB >> 6590919

Reduced antineoplastic activity in mice of cisplatin administered with high salt concentration in the vehicle.

S Aamdal, O Fodstad, O Kaalhus, A Pihl.   

Abstract

The effect of high NaCl concentration in the vehicle on the toxic and antineoplastic activities of cisplatin [cis-dichloro-diammineplatinum(II)] (CDDP) was reinvestigated in mice. The toxicity, as measured by the survival of mice given CDDP iv, was reduced by 50-60% when the NaCl concentration in the vehicle was raised from 0.9 to 4%. In ascitic P388 leukemia the antineoplastic activity of CDDP given ip was not reduced significantly. However, in all other systems studied the antitumor activity was reduced when the CDDP was dissolved in high NaCl solution. The tumor models studied included systemic P388 and L1210 leukemias, Lewis lung carcinoma, and 5 human tumor xenografts. The human tumors were studied by the subrenal capsule assay. In the case of a malignant melanoma and a malignant fibrous histiocytoma, the effect also was demonstrated in the subcutaneous nude mouse model. In one of the malignant melanomas a 50% increase in the CDDP dose did not compensate for the reduced antitumor activity caused by the high NaCl concentration in the vehicle. These results, which stand in contrast to current views, question the experimental basis for the use of high-NaCl vehicles in the "high-dose" CDDP regimens.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6590919

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  5 in total

1.  High-dose cis-platinum combination chemotherapy in advanced nonseminomatous malignant germ cell tumours with emphasis on nephrotoxicity.

Authors:  K S Hall; S D Fosså; M Aas
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Sodium thiosulfate fails to increase the therapeutic index of intravenously administered cis-diamminedichloroplatinum (II) in mice bearing murine and human tumors.

Authors:  S Aamdal; O Fodstad; A Pihl
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 3.  Evolution of high-dose cisplatin.

Authors:  W M Holleran; M W DeGregorio
Journal:  Invest New Drugs       Date:  1988-06       Impact factor: 3.850

4.  The effect of reduced osmolarity on platinum drug toxicity.

Authors:  E Smith; A P Brock
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

5.  Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice.

Authors:  A Kondo; M Maeta; A Oka; S Tsujitani; M Ikeguchi; N Kaibara
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.